Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease
Wnts are secreted, lipid-modified proteins that bind to different receptors on the cell surface
to activate canonical or non-canonical Wnt signaling pathways, which control various …
to activate canonical or non-canonical Wnt signaling pathways, which control various …
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
L Merkens, V Sailer, D Lessel, E Janzen… - Journal of Experimental …, 2022 - Springer
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …
Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
A Quintanal-Villalonga, H Taniguchi, YA Zhan… - Cancer discovery, 2021 - AACR
Lineage plasticity is implicated in treatment resistance in multiple cancers. In lung
adenocarcinomas (LUAD) amenable to targeted therapy, transformation to small cell lung …
adenocarcinomas (LUAD) amenable to targeted therapy, transformation to small cell lung …
The WNT/β‐catenin dependent transcription: A tissue‐specific business
S Söderholm, C Cantù - WIREs Mechanisms of Disease, 2021 - Wiley Online Library
Abstract β‐catenin‐mediated Wnt signaling is an ancient cell‐communication pathway in
which β‐catenin drives the expression of certain genes as a consequence of the trigger …
which β‐catenin drives the expression of certain genes as a consequence of the trigger …
[HTML][HTML] Cell plasticity in cancer cell populations
S Shen, J Clairambault - F1000Research, 2020 - ncbi.nlm.nih.gov
Cell plasticity in cancer cell populations - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance
C Wang, Q Chen, H Xu - Discover Oncology, 2021 - Springer
Globally, prostate cancer ranks second in cancer burden of the men. It occurs more
frequently in black men compared to white or Asian men. Usually, high rates exist for men …
frequently in black men compared to white or Asian men. Usually, high rates exist for men …
Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human …
F Li, X Ling, S Chakraborty, C Fountzilas… - Journal of Experimental …, 2023 - Springer
There is increasing evidence indicating the significant role of DDX5 (also called p68), acting
as a master regulator and a potential biomarker and target, in tumorigenesis, proliferation …
as a master regulator and a potential biomarker and target, in tumorigenesis, proliferation …
The genetic regulatory architecture and epigenomic basis for age-related changes in rattlesnake venom
MP Hogan, ML Holding, GS Nystrom… - Proceedings of the …, 2024 - National Acad Sciences
Developmental phenotypic changes can evolve under selection imposed by age-and size-
related ecological differences. Many of these changes occur through programmed …
related ecological differences. Many of these changes occur through programmed …
[HTML][HTML] WLS-Wnt signaling promotes neuroendocrine prostate cancer
Neuroendocrine prostate cancer (NEPC) is a lethal prostate cancer subtype arising as a
consequence of more potent androgen receptor (AR) targeting in castration-resistant …
consequence of more potent androgen receptor (AR) targeting in castration-resistant …
The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes
G Pizzolato, L Moparthi, S Söderholm… - Journal of cell …, 2022 - journals.biologists.com
The forkhead box transcription factor FOXQ1 contributes to the pathogenesis of carcinomas.
In colorectal cancers, FOXQ1 promotes tumour metastasis by inducing epithelial-to …
In colorectal cancers, FOXQ1 promotes tumour metastasis by inducing epithelial-to …